Picture of server farm and IT infrastructure

Where technology & law meet: Open Access research on data security & its regulation ...

Strathprints makes available Open Access scholarly outputs exploring both the technical aspects of computer security, but also the regulation of existing or emerging technologies. A research specialism of the Department of Computer & Information Sciences (CIS) is computer security. Researchers explore issues surrounding web intrusion detection techniques, malware characteristics, textual steganography and trusted systems. Digital forensics and cyber crime are also a focus.

Meanwhile, the School of Law and its Centre for Internet Law & Policy undertake studies on Internet governance. An important component of this work is consideration of privacy and data protection questions and the increasing focus on cybercrime and 'cyberterrorism'.

Explore the Open Access research by CIS on computer security or the School of Law's work on law, technology and regulation. Or explore all of Strathclyde's Open Access research...

Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii

El Bissati, Kamal and Chentoufi, Aziz A and Krishack, Paulette A and Zhou, Ying and Woods, Stuart and Dubey, Jitender P and Vang, Lo and Lykins, Joseph and Broderick, Kate E and Mui, Ernest and Suzuki, Yasuhiro and Sa, Qila and Bi, Stephanie and Cardona, Nestor and Verma, Shiv K and Frazeck, Laura and Reardon, Catherine A and Sidney, John and Alexander, Jeff and Sette, Alessandro and Vedvick, Tom and Guderian, Jeffrey A and Reed, Steven and Roberts, Craig W (2016) Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI Insight, 1 (15). ISSN 2379-3708

[img]
Preview
Text (Bissati-etal-JCI-2016-vaccines-protect-HLA-A1101-transgenic-mice-against-Toxoplasma-gondii)
Bissati_etal_JCI_2016_vaccines_protect_HLA_A1101_transgenic_mice_against_Toxoplasma_gondii.pdf
Accepted Author Manuscript

Download (3MB) | Preview

Abstract

We created and tested multi-epitope DNA or protein vaccines with TLR4 ligand emulsion adjuvant (gluco glucopyranosyl lipid adjuvant in a stable emulsion [GLA-SE]) for their ability to protect against Toxoplasma gondii in HLA transgenic mice. Our constructs each included 5 of our best down-selected CD8(+) T cell-eliciting epitopes, a universal CD4(+) helper T lymphocyte epitope (PADRE), and a secretory signal, all arranged for optimal MHC-I presentation. Their capacity to elicit immune and protective responses was studied using immunization of HLA-A*11:01 transgenic mice. These multi-epitope vaccines increased memory CD8(+) T cells that produced IFN-γ and protected mice against parasite burden when challenged with T. gondii. Endocytosis of emulsion-trapped protein and cross presentation of the antigens must account for the immunogenicity of our adjuvanted protein. Thus, our work creates an adjuvanted platform assembly of peptides resulting in cross presentation of CD8(+) T cell-eliciting epitopes in a vaccine that prevents toxoplasmosis.